Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product


More and more cancer patients get chemoport implants rather than get injections repeatedly on peripheral blood vessels, as cancer drugs sometimes damage the small vessels and the surrounding tissue. A chemoport is the most reliable and convenient method of central venous access. MEDITULIP developed TULIP PORT, a chemoport to maximize patient comfort and safety by making the housing thin and small and the septum wide yet pressure-resistant. TULIP PORT is power-injectable and supports X-ray, CT and MRI examinations. Moreover, MEDITULIP uses more expensive, implantable-grade polysulfone material. MEDITULIP received regulatory approval in South Korea and is preparing for regulatory approval of its chemoports in other countries.